4.4 Article

Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma

Related references

Note: Only part of the references are listed.
Review Medical Laboratory Technology

A review of S100 protein family in lung cancer

Ting Wang et al.

CLINICA CHIMICA ACTA (2018)

Article Oncology

Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma

Ken Katono et al.

ONCOLOGY RESEARCH AND TREATMENT (2017)

Article Oncology

Cancer Statistics in China, 2015

Wanqing Chen et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2016)

Article Oncology

S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtype

Sidse Ehmsen et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Review Oncology

S100 proteins in cancer

Anne R. Bresnick et al.

NATURE REVIEWS CANCER (2015)

Article Oncology

S100A14 Promotes the Growth and Metastasis of Hepatocellular Carcinoma

Fu-Tao Zhao et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)

Editorial Material Oncology

Ten Years of Progress in Non Small Cell Lung Cancer

David S. Ettinger

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)

Review Biochemistry & Molecular Biology

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

R Donato

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2001)